HEALTHMARK REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
HEALTHMARK REGIONAL MEDICAL CENTER is a 44-bed rural/critical access in WALTON, FL with $8.2M in net patient revenue and a -15.2% operating margin. The hospital serves a payer mix of 48.1% Medicare, 1.9% Medicaid, and 50.1% commercial.
Thesis: Turnaround. Our ML models identify $613K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.2% to -7.7% (+746bps).
| Net Revenue HCRIS | $8.2M |
| Current EBITDA COMPUTED | $-1.2M |
| Operating Margin COMPUTED | -15.2% |
| Occupancy HCRIS | 8.7% |
| Revenue / Bed COMPUTED | $187K |
| Net-to-Gross HCRIS | 28.4% |
| Distress Probability ML | 59.1% |
2. Market Context & Competitive Position
FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -15.2% places it below the state median. Among 85 size-comparable peers (22-88 beds), the median margin is 3.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (22-88), prioritizing same-state peers. 85 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HEALTHMARK REGIONAL MEDICAL CE (Target) | FL | 44 | $8.2M | -15.2% |
| ASCENSION SACRED HEART EMERALD | FL | 80 | $187.9M | 16.1% |
| VIERA HOSPITAL INC | FL | 84 | $162.9M | 16.9% |
| GULF BREEZE HOSPITAL | FL | 65 | $121.8M | 12.8% |
| OVIEDO MEDICAL CENTER | FL | 64 | $110.9M | 7.4% |
| SANTA ROSA MEDICAL CENTER | FL | 86 | $101.4M | 17.1% |
| ST. CLOUD REGIONAL MEDICAL CEN | FL | 84 | $97.1M | 1.2% |
| BARTOW REGIONAL MEDICAL CENTER | FL | 72 | $90.9M | 11.3% |
| BAPTIST MEDICAL CTR-NASSAU | FL | 54 | $85.1M | 2.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $613K (746bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $172K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $166K | +203bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $164K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $100K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +12bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-1.2M |
| + RCM Uplift | +$613K |
| Pro Forma EBITDA | $-634K |
| Current Margin | -15.2% |
| Pro Forma Margin | -7.7% |
| WC Released (1x) | $315K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.9M | $-2.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.9M | $-2.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.7M | $-1.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.7M | $-2.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-2.1M | $-4.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-2.1M | $-5.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 8.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 59.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 85 hospitals with 22-88 beds
- Same-state prioritization (n=86)
- Comp margins: P25=-18.0% / P50=3.1% / P75=11.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.